Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma

30 Jul 2022

Abstract excerpt

The chromodomain helicase DNA binding domain 5 (CHD5) is required for neural development and plays an important role in the regulation of gene expression. Although CHD5 exerts a broad tumor suppressor effect in many tumor types, its specific functions regarding its expression levels, and impact on immune cell infiltration, proliferation and migration in glioma remain unclear. Here, we evaluated the role of CHD5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35955624
DOI: 10.3390/ijms23158489

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for GliomaPMID 35955624Read ↗

Role of CHD5 in Human Cancers: 10 Years LaterSemantic proximity Read ↗

Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human gliomaSemantic proximity Read ↗

CHD7 promotes glioblastoma cell motility and invasiveness through transcriptional modulation of an invasion signatureSemantic proximity Read ↗

Molecular characteristics and oncogenic role of CHD family genes: a pan-cancer analysis based on bioinformatic and biological analysis.Semantic proximity Read ↗

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in gliomaSemantic proximity Read ↗

Analysis of COMMD10 Expression Patterns in Gliomas and Its Impact on Immune Cell Infiltration and Patient PrognosisSemantic proximity Read ↗

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including GliomasSemantic proximity Read ↗

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancersSemantic proximity Read ↗

Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancersSemantic proximity Read ↗

Pan-Cancer Multi-Omics Analysis Uncovers CHD4 Driving Tumor Progression via Epigenetic Regulation of Genomic Stability and the Immune MicroenvironmentSemantic proximity Read ↗

Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in gliomaSemantic proximity Read ↗

CHD4 regulates the DNA damage response and RAD51 expression in glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.